None listed
Conditions
Interventions
Intervention1: BBETTER PsoriaUrja capsules 500 mg.: One capsule after breakfast and dinner (twice daily) with ambient temperature water for 8 weeks.
Control Intervention1: Placebo Capsule (Identical t
Sponsors
MONKSAYS SUPERFOODS PVT. LYD.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants aged 18 to 65 years with mild to moderate plaque psoriasis (PASI score 5 to 15). 2. Presence of chronic stable psoriasis for at least 6 months. 3. Willingness to avoid additional psoriasis medications or phototherapy during the trial. 4. No recent use of systemic immunosuppressants (past 3 months). 5. Willingness to provide informed consent and comply with the study requirements.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Psoriasis Area and Severity Index (PASI) scores from baseline.Timepoint: Baseline, Week 4, Week 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Transepidermal Water Loss (TEWL) scores from baseline.Timepoint: Baseline, Week 4, Week 8;Change in Dermatology Life Quality Index (DLQI) scores from baseline.Timepoint: Baseline, Week 4, Week 8;Change in Short Form-12 (SF-12) for Quality of Life score from baseline.Timepoint: Baseline, Week 4, Week 8;Change in Patient Global Assessment (PGA) score from baseline.Timepoint: Week 4, Week 8;Change in Inflammatory Biomarkers (IL-6, TNF-a, CRP) from baseline.Timepoint: Baseline, Week 8;Change in oxidative stress markers (MDA, SOD) from baseline.Timepoint: Baseline, Week 8;Change in laboratory values for liver parameters (serum alanine transaminase, aspartate transaminase, alkaline phosphatase, bilirubin) from baselineTimepoint: Baseline, Week 8;Change in laboratory values for kidney parameters (serum creatinine, blood urea nitrogen) from baseline.Timepoint: Baseline, Week 8;Change in Treatment-Emergent Adverse Events (TEAEs) from baseline.Timepoint: Baseline, Week 4, Week 8;Change in Treatment-Emergent Serious Adverse Events (TESAE) from baseline.Timepoint: Baseline, Week 4, Week 8 | — |
Countries
India
Contacts
Public ContactDr Revathi Vavilapalli
Government Medical College & Govt. General Hospital
Outcome results
None listed